These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17456997)

  • 1. Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide.
    Nakahara T; Takata Y; Hirayama Y; Asano K; Adachi H; Shiokawa G; Sumi T; Ogawa T; Yamashina A
    Circ J; 2007 May; 71(5):716-21. PubMed ID: 17456997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of procollagen type III amino-terminal peptide is increased in patients with successfully repaired coarctation of the aorta with left ventricular hypertrophy.
    Yamazawa H; Murakami T; Takeda A; Takei K; Furukawa T; Nakajima H
    Pediatr Cardiol; 2015 Mar; 36(3):555-60. PubMed ID: 25311763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of aldosterone on the development of left ventricular geometry and hypertrophy in patients with essential hypertension.
    Soylu A; Temizhan A; Duzenli MA; Sokmen G; Koylu O; Telli HH
    Jpn Heart J; 2004 Sep; 45(5):807-21. PubMed ID: 15557722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
    dos Santos Moreira C; Serejo F; Alcântara P; Ramalhinho V; Braz Nogueira J
    Rev Port Cardiol; 2015 May; 34(5):309-14. PubMed ID: 25958256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension.
    Sato A; Hayashi M; Saruta T
    Hypertens Res; 2002 Nov; 25(6):837-42. PubMed ID: 12484506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
    Taniguchi I; Kawai M; Date T; Yoshida S; Seki S; Taniguchi M; Shimizu M; Mochizuki S
    Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship of Carotid Arterial Stiffness and Left Ventricular Concentric Hypertrophy in Hypertension.
    Jaroch J; Łoboz-Grudzień K; Magda S; Florescu M; Bociąga Z; Ciobanu AO; Kruszyńska E; Dudek K; Vinereanu D
    Adv Clin Exp Med; 2016; 25(2):263-72. PubMed ID: 27627559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients.
    Sato A; Takane H; Saruta T
    Hypertens Res; 2001 Mar; 24(2):99-104. PubMed ID: 11325081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of insulin resistance on left ventricular structural changes in hypertensive patients.
    Kaftan HA; Evrengul H; Tanriverdi H; Kilic M
    Int Heart J; 2006 May; 47(3):391-400. PubMed ID: 16823245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
    Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
    Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
    Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc Levels in Left Ventricular Hypertrophy.
    Huang L; Teng T; Bian B; Yao W; Yu X; Wang Z; Xu Z; Sun Y
    Biol Trace Elem Res; 2017 Mar; 176(1):48-55. PubMed ID: 27452612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of galectin-3 to left ventricular geometry and hypertrophy in chronic hemodialysis patients.
    Yilmaz H; Gurel OM; Celik HT; Bozkurt A; Yildirim ME; Bilgic I; Bilgic MA; Bavbek N; Akcay A
    Herz; 2015 Jun; 40(4):702-8. PubMed ID: 24924396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension.
    Iwashima Y; Horio T; Kuroda S; Takishita S; Kawano Y
    Hypertens Res; 2002 Jan; 25(1):49-56. PubMed ID: 11924725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure.
    Woodiwiss AJ; Libhaber CD; Majane OH; Libhaber E; Maseko M; Norton GR
    Am J Hypertens; 2008 Oct; 21(10):1144-51. PubMed ID: 18756261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between myocardial modelling and diastolic function in patients with essential hypertension].
    Cortés R; Roselló-Lletí E; Portolés M; Almenar L; Martínez-Dolz L; Grigorian L; García de Burgos F; Carpena N; Salvador A; Bertomeu V; Rivera M
    Med Clin (Barc); 2012 Oct; 139(8):325-30. PubMed ID: 22036455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between red-cell distribution width and abnormal left ventricle geometric patterns in patients with untreated essential hypertension.
    Kilicaslan B; Dursun H; Aydin M; Ekmekci C; Ozdogan O
    Hypertens Res; 2014 Jun; 37(6):560-4. PubMed ID: 24599016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.